Svenska
|
Site map
|
Contact
Home
Company
Products and Pipeline
Partners and distributors
Investors
Press
Contact
Investors
Annual reports
Financial reports
The stock
Investment presentations
Press releases
Financial calendar
Shareholders
Analysts
Corporate governance
CEO interview
Investors
/
Financial reports
Interim Reports -
Annual Reports
2013
5/2 2013 -
Year-end report 2012
2012
28/8 2012 -
Interim Report January-September 2012
28/8 2012 -
Interim Report January-June 2012
23/4 2012 -
Interim Report January-March 2012
9/2 2012 -
Year-end report 2011
2011
28/10 2011 -
Interim Report January-September 2011
12/8 2011 –
Interim Report January-June 2011
2/5 2011 -
Prospectus
(only available in Swedish)
18/4 2011 -
Interim Report January-March 2011
(only available in Swedish)
2010
21/2 2010 -
Year-end report
(only available in Swedish)
15/11 2010 -
Prospectus
(only available in Swedish)
13/10 2010 –
Interim Report January-September 2010
(only available in Swedish)
19/8 2010 –
Interim Report January-June 2010
(only available in Swedish)
Contact Investor relations:
Magnus Persson, IR
Phone: +46 733 55 26 01
Email:
magnus.persson@mobergpharma.se
Peter Wolpert, CEO
Phone +46 8 522 307 00
Email:
peter.wolpert@mobergpharma.se
Moberg Pharma AB (publ)
Gustavslundsvägen 42, 5 tr, SE-167 51 Bromma, Sweden
Phone: +46 8 522 30 700
info@mobergpharma.se
site policy
© Moberg Pharma AB 2013